RecruitingNCT07176767

The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents


Sponsor

Lena Xiao

Enrollment

82 participants

Start Date

Jun 12, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep. Studying how insomnia affects PAP adherence in children can help improve future treatments. However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.


Eligibility

Min Age: 8 YearsMax Age: 18 Years

Inclusion Criteria3

  • Children aged 8-18 years old
  • Obstructive apnea-hypopnea index ≥ 5/hour on baseline diagnostic polysomnogram (PSG)
  • Newly prescribed PAP therapy

Exclusion Criteria1

  • \) Developmental disability precluding ability to answer questionnaires

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPositive airway pressure therapy

Initiation of continuous or bilevel positive airway pressure therapy


Locations(1)

British Columbia Children's Hospital

Vancouver, British Columbia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07176767


Related Trials